Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Retained Earnings (2023 - 2025)

Metagenomi (MGX) has disclosed Retained Earnings for 3 consecutive years, with -$310.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 43946.26% to -$310.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$310.9 million, a 43946.26% decrease, with the full-year FY2025 number at -$310.9 million, down 43946.26% from a year prior.
  • Retained Earnings was -$310.9 million for Q4 2025 at Metagenomi, down from -$288.3 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $709000.0 in Q4 2024 to a low of -$310.9 million in Q4 2025.
  • A 3-year average of -$143.7 million and a median of -$170.1 million in 2024 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: surged 100.49% in 2024, then tumbled 43946.26% in 2025.
  • Metagenomi's Retained Earnings stood at -$144.9 million in 2023, then soared by 100.49% to $709000.0 in 2024, then crashed by 43946.26% to -$310.9 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Retained Earnings are -$310.9 million (Q4 2025), -$288.3 million (Q3 2025), and $372000.0 (Q2 2025).